Oral Contraceptive Pills: Access and Availability
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
2026
Read More
Banks Are Becoming Bulwarks Against Scams for Vulnerable Seniors
The first call came just before Thanksgiving last year. She didn’t recognize the phone number, but she answered anyway. “The person said he was an officer of the Department of Criminal Investigations looking into drug trafficking and money laundering,” the woman recalled. He seemed to know a lot about her: the states where she and…
More Kids Are in ERs for Tooth Pain. Trump Cuts and RFK Jr.’s Anti-Fluoride Fight Aren’t Helping.
Eight-year-old Jonah woke up one May morning with a swollen face and a toothache. He refused the pain medication that his mom, Geneva Reynolds, tried to give him. He didn’t sleep or eat and cried constantly. Within a few days, Reynolds became so desperate that she and her husband had to physically restrain Jonah, dumping…
Liberal Arts Education As a Counterbalance To Trumpian AI
By MIKE MAGEE What’s wrong in the social science realm of health? Consider for example the mental health crises affecting teens across the nation, or the sharp decline in relationships and child bearing in young adult men and women, or the attack on vaccine policy by the wayward Kennedy, or the attempted dismantling of ACA…
Respondent selection of dominated choices in discrete choice experiments
Discrete choice experiments quantify respondent preferences over different alternative treatments due to their attributes. DCE assume individuals are rational and do not pick dominated options (i.e., where one option is weakly better than another option across all attributes and strictly better than the option across at least one attribute). However, Johnson et al. (2019) finds…
Verily & Samsung Team Up to Bring Smartwatch Data into Clinical Trials
Verily and Samsung are partnering to integrate data from Galaxy smartwatches into Verily’s Pre platform. The goal is to create an end-to-end system that pharma researchers can use to deploy wearable devices in studies, analyze patient data remotely and then interpret the results. The post Verily & Samsung Team Up to Bring Smartwatch Data into…
Eight Sleep Raises $50M to Build Predictive AI for Sleep
Eight Sleep’s $50 million raise was led by Tether Investments. In total, Eight Sleep has raised over $250 million, and this round brings the company’s valuation to $1.5 billion. The post Eight Sleep Raises $50M to Build Predictive AI for Sleep appeared first on MedCity News.
Traversing the Headwinds of Healthcare Transformation
Keynote speakers at HIMSS26 stress that overcoming fear and strategically repositioning are essential for healthcare organizations to survive and thrive through future headwinds
UHS Buying Talkspace to Boost Virtual Behavioral Lineup
The acquisition has an enterprise value of more than $830 million and will bring to UHS a network of roughly 6,000 licensed therapists.
Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision
GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma’s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concerns from U.S. and European regulators. The post Alfasigma Pays $300M for Rights to GSK Rare Liver…